Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study

  • Atul T. Patel,
  • Mark F. Lew,
  • Khashayar Dashtipour,
  • Stuart Isaacson,
  • Robert A. Hauser,
  • William Ondo,
  • Pascal Maisonobe,
  • Stefan Wietek,
  • Bruce Rubin,
  • Allison Brashear

In Fig 2, the delta and p-value are missing for the last available post-baseline assessment. The missing information reflects a statistically significant difference in the mean TWSTRS total score of aboBoNT-A vs placebo at the last available data point. Please see the correct Fig 2 here.

thumbnail
Download:
Fig 2. Mean TWSTRS total score.

aboBoNT-A = abobotulinumtoxinA; ITT = intent-to-treat (all randomized patients); last available* = last available post-baseline (end of study or early withdrawal); TWSTRS = Toronto Western Spasmodic Torticollis Rating Scale; Δ = weighted overall treatment difference. Error lines indicate standard deviation. *Last available = last available post-baseline (end of study or early withdrawal), mean (SD) study drug exposure: 62.6 (37.8) days.

https://doi.org/10.1371/journal.pone.0250475.g001

Reference

  1. 1. Patel AT, Lew MF, Dashtipour K, Isaacson S, Hauser RA, Ondo W, et al. (2021) Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study. PLoS ONE 16(2): e0245827. https://doi.org/10.1371/journal.pone.0245827 pmid:33524060

Citation: Patel AT, Lew MF, Dashtipour K, Isaacson S, Hauser RA, Ondo W, et al. (2021) Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study. PLoS ONE 16(4): e0250475. https://doi.org/10.1371/journal.pone.0250475

Published: April 14, 2021

Copyright: © 2021 Patel et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.